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Background: Polypharmacy can be defined as the use of multiple medicines by a single 
patient and includes inappropriate medicine use. This is common among the elderly, 
especially in patients 60 years and older. The use of multiple medicines has been shown to 
predispose patients to adverse medicine reactions.  
Objective: The goal of this study was to determine if polypharmacy is prevalent in geriatric 
patients in a private hospital in KwaZulu-Natal, Pietermaritzburg, and if so to determine the 
extent of the problem.  
 Methods: A cross sectional descriptive study involving chart review of geriatric patients was 
carried out in a hospital. Prescriptions were reviewed for concomitant use of five or more 
medicines, adverse medicine reactions, therapeutic duplication, contraindications and 
inappropriate use of medicines. Demographic data e.g. age, sex, and medical aid 
membership were reviewed. Diagnosis, allergies and number of chronic disease states were 
also analysed.  
Results: The majority of the patients reviewed had between one to two chronic diseases. 
The youngest age group 60-69 years age had the most number of patients with between 1-2 
chronic diseases. Females outnumbered males in all three age categories reviewed. The 
most common chronic disease was hypertension. The 120 study patients were prescribed a 
combined total of 859 medicines. The average number of medicines per patient was 7.2 
(used to determine the degree of polypharmacy) ranging from two to twenty one. A total of 
75 % (n=90) of the study patients received 5 and more medicines. Prescription medicine use 
was assessed according to gender of the study population. Polypharmacy was more 
prevalent in females when compared to the males. Polypharmacy was prevalent in each age 
category with the 60-69 years age group having the highest prevalence. Polypharmacy was 
evident from the results obtained.  
Conclusion: Prescribing trends in geriatric patients together with inappropriate medicine use 
were identified. The results of this study can be used by healthcare professionals to be 
aware of the prevalence of polypharmacy in their settings. Health care professionals can 
adopt an informed approach to address the needs of the geriatric population regarding 





review, communication with the prescriber and patient, reduction in a geriatrics regimen to 
the fewest possible essential medicines. Prescribers and dispensers can utilize the 
information to decide whether the medicine is essential and if the geriatric can tolerate 
possible interactions or adverse effects.  
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Chapter 1: Introduction and Background to the Study 
  
1.1 Introduction  
John J. Castellani (PhRMA, 2013) who is the President and Chief Executive Officer of 
Pharmaceutical Research and Manufacturers of America, stated that there are daunting 
health care challenges, with a higher incidence of chronic diseases, and these are becoming 
more of a burden due to the cost implications of therapy. Rare conditions like cancer, 
Alzheimer’s disease, and Parkinson’s disease are also on the increase. The medical needs of 
a population that is getting older is a unique challenge that requires addressing. Research 
and the development of new medicines are important in addressing the needs of an ageing 
population. The discovery of new medicines offers many ill individuals around the world 
hope for a cure or chronic treatment that will help them live a longer and healthier life 
(PhRMA, 2013). There is a greater demand for the treatment of chronic conditions as 
individuals grow older. Declining physiological, physical, mental and cognitive functional 
capacities in these ageing persons leads to an increase in the prevalence of chronic disease. 
This results in an increasing number of older individuals who need greater health and 
related care which places rising demands on the health care system (Joubert & Bradshaw, 
2005).  
 
Rational use of medicines is defined to ensure that patients receive medicines “appropriate 
to their clinical needs, in doses that meet their own individual requirements, for an 
adequate period of time, at the lowest cost to them and their community”. Irrational use of 
medicines continues to be a major problem worldwide in terms of the use of too many 
medicines per patient (polypharmacy); inappropriate use of antimicrobials, inadequate 
dosages of medicines for non-bacterial infections; over-use of injections when oral 
formulations would be more appropriate; failure to prescribe in accordance with clinical 
guidelines; inappropriate self-medication of prescription-only medicines, and non-





The rational use of medicines in an appropriate and effective way is very important in order 
to optimise the function of these medicines and to avoid adverse health outcomes. This is 
essential in older patients (Hilmer, 2008).  
 
1.2 Background to the Study  
According to The National Drug Policy (NDP) for South Africa in 1994, “the health care of the 
South African population is characterized by  
a two-tier system consisting of private healthcare funded by medical aid and the public 
sector which is known for fragmentation (no less than 10 health authorities). This is largely 
inefficient due to a shortage of staff, a shortage of medication, inefficient use of resources, 
poor working conditions and inadequate infrastructure”  (National Drug Policy for South 
Africa, 1994).    
 
The private sector health care expenditure in 1992/93 comprised of 48.5 % of total health 
care expenditure that was responsible for 80 % of the country's total expenditure on 
medicines, although 60-70 % of the total volume of pharmaceuticals was consumed in the 
public sector. This resulted in a lack of equity in access to essential medicines. Consequently 
there was a negative impact on quality of care. The increasing cost of medicines, irrational 
use of medicines, major loss through malpractice and inefficient security systems, ineffective 
cost procurement and logistic practices became a huge concern. The South African 
government decided to tackle the disparities through the development and implementation 
of a National Drug Policy that would be consonant with and an integral part of the new 
National Health Policy, which aims at equity in the provision of health care for all. The goal of 
the National Drug Policy is to ensure an adequate and reliable supply of safe, cost-effective 
medicines of acceptable quality to all citizens of South Africa and the rational use of 






The percentage of the population aged 60 years and above in South Africa rose from 7.1 % 
in 1996 to 8 % in 2011, constituting an increase from 2, 8 million to 4, 1 million individuals. 
The report, which is based on the three population censuses of 1996, 2001 and 2011, 
provides valuable information on the demographic and socio-economic profiles of the 
elderly population (Statistics South Africa, Census, 2011).   
  
The common characteristics of old age are frailty, multiple morbidities and disabilities. This 
leads to an inability to perform various functions that many take for granted, e.g. walking, 
hearing, vision, memory, concentration and self-care. These become increasingly difficult 
with age. According to the Census results elderly women experience far higher levels of 
severe difficulty in a number of functional domains compared to elderly men. Many geriatric 
persons increasingly rely on assistive devices and chronic medicines. In South Africa a 
substantial proportion of elderly persons use chronic medicines (38 %) by age 60–64 
(Statistics South Africa, Census, 2011).  
  
Polypharmacy (the use of multiple medicines or the administration of more medicines than 
are clinically indicated) is common among the elderly (Viktil et al., 2008). Evidence based 
guidelines recommend several medicines in the treatment or the prevention of a single 
medical condition. This is relevant to the treatment of heart failure, diabetes mellitus, 
prevention of new cardiovascular events after myocardial infarction, and prevention of the 
progression of rheumatoid arthritis. An ageing population implies more co-morbidity. 
Consequently, many people are in need of several medicines, which can result in 
polypharmacy.  
  
Geriatric persons often have limited regenerative abilities. They are more prone to chronic 
disease and other ailments than younger adults. The use of prescription medicines in 
geriatric patients has increased considerably in United States of America. Geriatric persons, 
65 years and older use one third of all medicines prescribed. This is disproportionate to the 





Cognitive and physical impairment are common adverse effects of different medicines. 
Geriatric patients are at risk for falls, motor vehicle accidents or unable to care for day to 
day needs when using these medicines. Geriatric persons often experience a mixture of 
social-emotional, physical and functional changes. Multiple chronic diseases, metabolic 
changes (medicine potency is affected), hormonal changes (e.g. change in melatonin levels 
resulting in altered sleep/wake cycles, menopause) and psychiatric problems worsen their 
health problems. Depression is not a geriatric problem but does affect many geriatric 
patients. Arthritis and osteoporosis affects the mobility and dexterity of geriatric persons 
slowing them down (Basca, 2008).  
  
Normal physiological changes that occur with ageing place geriatric patients at a greater risk 
of adverse effects. They visit multiple doctors. One doctor is not aware of knowing the exact 
doses or the medicines that a patient has been prescribed by another doctor. Accurate 
record- keeping is hampered by impaired cognitive functions and communication problems 
of the geriatric patient. The risk/benefit ratio of a treatment that can be used in geriatric 
patients is difficult to assess as they are often excluded from medicines trials. This creates 
uncertainty for the clinician attempting to make a decision regarding how to treat an older 
adult with a new illness, recent discharge from a hospital, or exacerbation of a chronic 
illness (Halloran, 2013). Geriatric patients are often confused about using medicines. This is 
compounded by any hospital admission during which additions or changes are often made 
to medicines for reasons patients do not understand (Johnson, 2009).  
  
It is of utmost importance that healthcare providers understand the pharmacodynamic and 
pharmacokinetic changes that occur with aging and their clinical importance on medicine 
metabolism. Metabolic changes have a clinical significance. They may increase the 
concentration and half-life of medicines resulting in adverse effects. Elimination changes 
should be considered, e.g. there might be an increase in the concentration of a medicine 
that is eliminated renally. These and other factors discussed below must be considered by a 






Many of the prescribing guidelines are not for multiple chronic conditions. However, most 
geriatric patients have more than one chronic condition. This places them at a greater risk of 
medicine-medicine interactions. A new medicine added to the treatment plan may result in 
an adverse reaction. This adverse reaction is often mistaken for a new health problem. A 
vicious circle of testing, more medicines, more medicine/medicine interactions, and more 
adverse events follows (Halloran, 2013). Medicines are becoming more available to patients 
by means of the internet and self-medication, worsening the existing problems experienced. 
(Viktil et al., 2008).  
  
For decades physicians have been entirely responsible for managing their patient’s chronic 
conditions and complicated treatment plans. In recent years, as the world of pharmacy 
evolves, pharmacists are becoming increasingly responsible for patients. They are more 
involved in managing patients’ treatment plans. They conduct medicine utilization reviews 
of the treatment plan and counsel patients. They also provide patient and physician 
education on the treatment plans (Chumney & Robinson, 2006).  
  
Hepler & Strand (1990), stated that a medicine related problem exists when a patient 
experiences or is likely to experience either a disease or symptom having an actual or 
suspected relationship with their medicine. The author also recommends categorization of 
medicine related problems that can allow for a systematic process for pharmacists to be 
developed in order to contribute significantly to positive patient outcomes. WHO defines an 
adverse medicine reaction as “a reaction that is noxious and unintended, and which occurs 
at dosages normally used in humans for prophylaxis, diagnosis or therapy” (WHO, 1985).  
  
The importance of pharmacists in health care teams is increasingly being recognised. 
Medicine reviews by pharmacists lead to major reductions in morbidity and health care 
costs. High quality cost effective care for each geriatric patient is attainable by the safe, 






Clinical pharmacy services have a positive impact on patient outcomes. This is recognised in 
the United Kingdom (UK) and other parts of the world. It is also becoming increasingly 
evident, especially during the last twenty years. The UK has acknowledged that pharmacists’ 
clinical skills and expertise are an integral part of delivering better services to patients in the 
2008 Pharmacy White Paper. This was reinforced in 2010, by identifying the role of 
pharmacists in optimising the use of medicines. Examples of the positive impact made by 
pharmacists include reductions in medicine-related adverse events, reductions in the cost of 
medicine therapy, improved patient outcomes, reductions in duration of hospitalisation and 
reductions in readmission rates (Child et al., 2010).  
  
The systematic review of a patient’s treatment plan may help to determine how to improve 
inappropriate prescribing in older people. Inappropriate prescribing is often interlinked with 
polypharmacy. Interventions that are effective in managing disease with appropriate 
polypharmacy must be identified and put into practice (Patterson, 2012).  
  
Polypharmacy includes inappropriate medicine use which includes the use of prescription or 
non-prescription (over the counter) medicines that have no legitimate indication, 
simultaneous use of interacting medicines, inappropriate medicines or dosage and the use 
of medicines to counteract the side effects of another medicine. Risks associated with 
polypharmacy include, non-compliance with medicine therapy, over/under dosage of 
medicine, therapeutic duplications, off-label use of medicines, contra-indicated use of 
medicines, medicine-medicine interactions, adverse medicine reactions, increasing medicine 
expenses, and excessive use of vitamins and herbal preparations (Hill, 2012).  
  
Pharmacists can reduce or avoid polypharmacy in prescriptions in numerous ways. These 
include: reviewing of patient medicines, assessing effects of multi-morbidity and reviewing 
potential medicine-medicine interactions (Terrie, 2004). The most commonly used 





(NSAIDS), antipsychotics, antihypertensives, and antibiotics. It is imperative that each 
medicine and its indication are reviewed (Terrie, 2004).  
  
Pharmacists can recommend discontinuation of medicines used to treat adverse effects of 
other medicines. They can suggest alternative treatment. Pharmacists are able to identify 
unnecessary medicines in a patient's treatment plan. They can also suggest non-
pharmacologic treatment. The solution may be difficult. However polypharmacy can be 
managed by multidisciplinary teamwork. The ideal pharmacologic treatment plan of patients 
is to treat all the chronic conditions, to prevent any complications from multiple morbidities 
and to stop or decrease any pain. Regular monitoring of treatment plans can assist in 
reaching these objectives (Terrie, 2004).   
  
The greatest challenge for every health care professional is to ensure the most appropriate 
medicine is being given to each patient. Improvement in quality of life without affecting the 
geriatric patients’ ability to function is a key factor. Any medicines prescribed and dispensed 
should also not place the patient at greater risk for adverse reactions (Terrie, 2004).  
Various strategies for managing polypharmacy include (Woodruff, 2010):   
  
 Information: Patients should be educated on keeping an up to date list of all 
medicines (this must include the generic and trade names), dosages and dosing 
frequency. They must be aware of the indication for each medicine. They must have 
a list of all the medical providers, including the pharmacist with their telephone 
numbers.  
  Instruction: Patients should be educated about each medicine. They must be taught 
about its name, appearance, indication, adverse effects and medicine interactions. 
The importance of contacting the doctor or pharmacist with any medicine related 
queries must be emphasized. They must also be counselled on the importance of 
taking medicines exactly as directed. They should use one pharmacy to dispense 





  Organization: Patients should be educated on management of their medicines. This 
includes storage (safe, dry place away from sunlight, refrigerated items must be 
refrigerated), expiry date checks (dispose of expired medicines in a safe way) and 
encourage them not to share medicines. Due to a decrease in cognitive function, 
advise patients on the use of memory aids. This includes use of color-coded charts, 
automatic dispensers with bells, or voice-activated message services to remind 
them to take their doses.  
 
All of the above information indicated a need to carry out this study.  There are many 
challenges facing doctors and pharmacists regarding the prescribing and dispensing of 
appropriate medicines to the geriatric patient population. It is also important to ensure that 
the number of appropriate medicines does not lead to polypharmacy which can lead to 
many risk factors, especially in this patient population. In my own experiences as a 
pharmacist in the private sector, I found myself reviewing many geriatric prescriptions 
where polypharmacy was prevalent. This was a matter of enormous concern to me. 
 
Polypharmacy is prevalent among the geriatric population because many different chronic 
diseases need to be treated as the patient grows older. The prevalence of polypharmacy 
leads to increased medicine costs, medicine interactions, non- compliance, adverse effects, 
decreased functional status and geriatric syndromes. More implementation studies are 
needed to show that practical application of the methods shown to improve polypharmacy 
issues can be disseminated to the various health care settings where geriatric patients are 
treated (Hajjar et al, 2014).  
 
This study was therefore conducted to determine the burden of polypharmacy in the 
geriatric patient population in a private hospital setting in KwaZulu- Natal, South Africa, for 





implementing suitable strategies to minimize polypharmacy not only at the study site but at 
other healthcare settings as well. 
  
1.3 Aim and Objectives of Study  
 The aim and objectives of this study include the following:  
1. To determine the prevalence of polypharmacy in geriatrics.  
2. To determine the reasons for multiple medicine prescriptions based on the health 
status, chronic diseases and number of medicines.  
3. To determine if appropriate management processes were followed.  
 
1.4 Outline of Dissertation  
1.4.1 Chapter One  
Chapter one focuses on the reasons for the research. Included in this chapter are 
background information, research questions and objectives, aim of the study as well as the 
research problem.  
  
1.4.2 Chapter Two  
Chapter two focuses on the literature surrounding the research topic. The chapter reviews 
what other authors have discussed regarding polypharmacy in geriatric patients.  
 
1.4.3 Chapter Three  
Chapter three focuses on the methodology used in completing the research. This chapter 





used in sampling of the target population. Details surrounding reliability, validity and 
method used in administering the survey are elaborated in this chapter.  
 
1.4.4 Chapter Four  
Chapter four focuses on presenting the results of the study. The chapter provides analysis of 
data collected. Findings are tabulated.  
   
1.4.5 Chapter Five  
Chapter five focuses on a discussion of the results in relation to the research questions and 
objectives.   
  
1.4.6 Chapter Six  
Chapter six focuses on concluding the research questions as well as strategies for 
pharmacists to manage polypharmacy in geriatric patients.   
  
1.5 Conclusion  
The general idea and purpose of the study has been outlined in this chapter. The main aims, 
objectives and method have been presented. An overview of the different chapters in the 







Chapter 2: Literature Review   
  
2.1 Introduction  
A literature review is an evaluation of selected/related documents on a research topic. A 
critical review of various studies is explored in this chapter. This chapter will also discuss 
various aspects of polypharmacy in geriatric patients.   
  
A Pub-Med search using the search string (polypharmacy in geriatrics, private hospital, 
South Africa) found no studies have been conducted in the private healthcare sector that 
dealt specifically with determining the prevalence of polypharmacy in geriatrics in South 
Africa as at November 2014. However similar studies have been conducted in other 
countries which will be covered in the literature review.   
  
2.2 Geriatric Polypharmacy  
A PubMed search on the term polypharmacy yielded 4852 hits on 7 November 2014. A 
review of the literature was conducted. English articles were searched for links between 
polypharmacy and geriatric patients from the age of sixty and over. A few articles that did 
not meet the age criterion (referred to the elderly from as young as 50) were reviewed if 
there was relevant information to be considered.   
  
There are many definitions of the term polypharmacy. McGraw-Hill Concise Dictionary of 
Modern Medicine (2002) defines polypharmacy as the use of multiple medicines to treat 
one or a limited number of conditions; it is most common in elderly. Wikipedia defines 
polypharmacy as the use of multiple medicines by a patient, generally older adults (those 
aged over 65 years). More specifically, it is often defined as the use of four or more regular 
medicines. It sometimes alternatively refers to purportedly excessive or unnecessary 





Polypharmacy is most common in the elderly, affecting about 40 % of older adults living in 
their own homes (Wikipedia, 2014).   
 
Polypharmacy can be defined as the concurrent use of five or more medicines by the same 
patient. Polypharmacy involves more than the number of medicines that a patient takes. 
Clinically, the criteria utilized for identifying polypharmacy involve the following: Taking 
medicines that have no apparent indication, therapeutic duplication to treat the same 
illness, simultaneous usage of interacting medicines, under/over dosage, and utilizing other 
medicines to treat adverse medicine reactions (Terrie, 2004).  
  
For this study polypharmacy is defined as the use of multiple medicines or the 
administration of more medicines than are clinically indicated, representing unnecessary 
medicine use (Viktil et al., 2008).  
  
2.3 Classes of Polypharmacy  
 Polypharmacy can be categorized into 2 major classes (Terrie, 2004):  
  Therapeutic Polypharmacy: This type occurs when polypharmacy is carefully 
reviewed and monitored by health care teams. These medicines are needed for the 
treatment of conditions and for achieving a therapeutic goal. An example of 
therapeutic polypharmacy is the combination therapy of isoniazid, rifampicin, 
ethambutol, pyrazinamide, and pyridoxine in the initial treatment of tuberculosis.  
Another example of therapeutic polypharmacy is the numerous medicines used in 
the management of congestive heart failure, such as digoxin, angiotensin-converting 
enzyme inhibitors, and a diuretic.    
 Contratherapeutic Polypharmacy: This type of polypharmacy occurs when a patient 
experiences adverse effects while he or she is on a treatment plan that is not 
reviewed and monitored. Polypharmacy has negative consequences when a patient 






2.4 Risk Factors for Polypharmacy  
Numerous risk factors for polypharmacy have been identified. These include: demographic 
characteristics (increasing age, white race, level of education), health status (declining 
health, depression, hypertension, incontinence, asthma, angina, diverticulosis, 
osteoarthritis, gout, diabetes mellitus, and use of 9 or more medicines) and healthcare 
characteristics (number of doctor visits, medical aid membership, multiple providers) (Hajjar 
et al., 2007).  
 
Hovstadius & Petersson (2012), emphasize that the most prominent risk factors for 
polypharmacy are those associated with socio-demographics and the patients’ conditions. 
Patient’s self- medication with all types of medications, and risk factors related to physicians 
(the interaction between patient and physician, the large variation in physicians’ individual 
prescribing practices, in terms of polypharmacy), are also problematic. Abdulraheem (2013) 
highlights that polypharmacy is a risk factor itself for geriatric syndrome, morbidity and 
mortality. 
 
2.5 Consequences of Polypharmacy  
The Department of Health and Human Services report Healthy People 2000 considers 
polypharmacy to be an enormous problem with far reaching consequences. It was listed as 
the principal medicine safety issue (Davis, 2010).  
 
Polypharmacy may result in a variety of consequences. These include non-adherence, a very 
common problem in the geriatric persons (prevalence averaging 50 %), inappropriate 
prescribing (higher risk of inappropriate medicines as defined by the Beers criteria), 
increased risk of adverse medicine reactions (results in 12 % of hospital admissions in 
geriatrics), geriatric syndrome (higher risk of cognitive impairment, falls, hip fractures) and 
morbidity/ mortality (decline in physical and instrumental activities of daily living) (Hajjar et 





Geriatric patients with multimorbidity have an altered ability to metabolize and excrete 
medicines. Together with sensory and cognitive deficits and complex treatment plans, 
geriatric patients present a challenge to healthcare workers treating them. Polypharmacy is 
often linked to a higher risk of over the counter medicine errors, poor quality of life and 
unnecessary medicine expense (Hippisley-Cox et al., 2004).   
  
Hippisley- Cox et al., (2004) analysis of polypharmacy in geriatric patients found 11 % of 
people in 65-74 years age group, 15 % in the 75 years and over age group concurrently used 
five or more medicines. They also reviewed a health survey for England which revealed 
higher rates of polypharmacy in people over 75 years. Educated older women were more 
likely to engage in polypharmacy, and people over 65 years (unskilled or partly skilled) had 
an increased chance of polypharmacy. They also confirmed that geriatrics living in 
institutions and hospitalised patients were more likely to be exposed to polypharmacy 
(Hippisley-Cox et al., 2004).  
  
2.6 The Geriatric Age  
WHO (2000) confirms that The Minimum Data Set (MDS) Project collaborators agreed at the 
2000 Harare MDS Workshop to use the chronological age of 60 years as a guide for the 
working definition of "old".  The western world accepts the chronological age of 65 years as 
a definition of 'elderly' or older person. However this does not apply in Africa. The geriatric 
age can also refer to the age a person begins to receive pension benefits. The United 
Nations has reached a consensus that 60 years and older is the geriatric age. In Africa, the 
geriatric age starts between 50-55 years of age. The more traditional African definitions of 
an elder or 'elderly' person correlate with the chronological ages of 50 to 65 years, 
depending on the setting, the region and the country. The age of 60 or 65 years, roughly 
equivalent to retirement ages in most developed countries is said to be the beginning of old 






A prospective study to evaluate the use of percutaneous transluminal coronary angioplasty 
in elderly coronary artery disease patients aged 60 years and older by Forman et al., (1992) 
divided them into the young old (60 to 69 years), the middle old (70 to 79 years), and the 
very old (80 years and older) to clarify differences between the age groups. Subdivision by 
age resulted in the majority of patients being male aged 60-69 years. Procedure 
complications and a higher prevalence of multi vessel disease were found as patients’ age 
increased. Older patients had a prolonged hospital stay. For this study the subjects were 
placed into the age categories 60-69 years, 70-79 years and 80 years and older (Forman et 
al., 1992).  
 
2.7 Pharmaceutical Care  
Hepler and Strand’s (1990) definition of pharmaceutical care, “the responsible provision of 
medicine therapy for the purpose of achieving definite outcomes which improve the 
patient’s quality of life”, included pharmacist input in the design, implementation and 
monitoring of a therapeutic plan, in collaboration with the patient and other healthcare 
professionals, and helped to change the focus of clinical pharmacy activities from processes 
to achieving a therapeutic outcome. Pharmacy, by definition, is a clinical profession and thus 
clinical pharmacy is a patient-centred service where the pharmacist is a key member of the 
multidisciplinary clinical team (Gillespie, 2012).   
  
The co-ordination of all medicine treatments for an individual patient, across sites, 
providers, and over time is greatly needed. Such a seamless continuum may represent the 
next stage in the evolution of geriatric pharmaceutical care (Nash et al., 2000).  
  
A clinical intervention can be defined as the process of identifying a medicine related 
problem and making a recommendation in an attempt to remedy or stop it. A pharmacist’s 
suggestions to patients or doctors might not be taken into consideration or even used, but 
the provision of these recommendations would still be considered a clinical intervention 





The newest medicines on the market often improve the health and quality of life of geriatric 
patients afflicted by multi-morbid conditions. The geriatric population is diverse with 
specialized healthcare needs. Pharmaceutical care for each geriatric patient must be 
individually tailored to each patient based on his or her specific health status. There is 
considerable variation from patient to patient. There is no one “best practice” for treating 
every patient. Physiological changes due to ageing, enormous variation in the properties of 
medicines used to treat geriatric patients and multi-morbid conditions create many 
complications in geriatric treatment (Nash et al., 2000).  
  
2.8 Medicine Related Problems in Geriatric Patients, South Africa  
A South African intervention study was conducted in 2000 to determine medicine related 
problems among geriatric patients visiting the outpatient pharmacy at a public sector 
hospital. A sample size of 280 was considered sufficient to ensure 5 % tolerated error for 
this population size and the final selection of 281 geriatric patients was used in the study. 
This sample of 281 was representative of the study population at Addington Hospital in 
Durban.  
  
Most geriatric subjects suffered from multiple chronic conditions which included: 
hypertension, ischaemic heart disease, musculoskeletal disorders (arthritis or gout), 
diabetes, chronic obstructive airways disease, hypercholesteremia and arrhythmias (atrial 
fibrillation). A shockingly high percentage of the geriatric patients were using from 7 to 9 
medicines and a considerable percentage were using from 10 to 15 medicines (Moodley, 
2000).   
The antihypertensives were the most widely prescribed medicines followed by medicines 
acting on the central nervous system (CNS), coronary vasodilators, diuretics and medicines 
acting on the musculoskeletal system. Medicine related problems experienced by geriatric 
patients ranged from 1 to 11. The greater the number of prescribed medicines, the greater 





medicine related problems were those involved in medicine safety; effectiveness of the 
medicine therapy; compliance and indication of medicine therapy (Moodley, 2000).  
  
The most common adverse medicine reactions (AMRs) were as follows: gastro-intestinal 
(GIT) ulceration, cough, diuretic side effects (dehydration, fatigue, hypotension, etc.), 
constipation, equilibrium problems and headaches. The most common prescription 
interventions were on problems involving medicine therapy monitoring, safety of medicine 
therapy, indication of medicine therapy, prescribing errors and prescription information 
omission (Moodley, 2000).   
  
Even though the main aim of this study was to determine medicine related problems in 
geriatric patients a small section reviewed polypharmacy (Moodley, 2000).  
  
2.9 Prevalence of Polypharmacy in Geriatric Patients Internationally  
A cross-sectional study by Carvalho et al., (2011) was conducted on 440 medical records in 
Sao Paulo, Brazil to determine the prevalence of polypharmacy in geriatric patients. 
Associations were determined between polypharmacy and socio-demographic variables, 
clinical variables, access to health services and self-reported health conditions extracted 
from personal information, health status, medicines, and access to health services, work 
history and sources of income sections of the questionnaire. Medicines were classified 
based on the Anatomical Therapeutic Chemical (ATC) classification system, which is divided 
into five levels. The variables included gender, age, reasons for admission, comorbidities, 
and medicines used by the geriatric patients. Patients were predominantly male (51.6 %) 
(Carvalho et al., 2011).   
The total number of medicines used was 5904, with an average of 13.4 per person. The 
three most commonly used medicines were dipyrone, omeprazole, and metoclopramide. 
The most frequently used medicines according to the ATC system were those of the 





types of medicines used, 42 (16.4 %) were included in the Beers list, and the three most 
often used were metoclopramide, ketoprofen, and aspirin (Carvalho et al., 2011).  
  
Regarding diseases, 67.8 % had hypertension, 23.6 % had diabetes, 10.6 % had lung disease, 
36.4 % had rheumatic disease and 25 % had heart disease. Thirty-six percent of the 
interviewees, representing 151 902 elderly individuals, reported taking five or more 
medicines. The multiple regression analysis revealed that the following factors remained 
positively associated with polypharmacy: female gender; age over 75 years; higher income; 
health self-rated as fair and poor/very poor; self-reported hypertension, diabetes, rheumatic 
disease and heart disease; and being currently employed (Carvalho et al., 2011). Exclusive 
use of the public healthcare system was associated with a lower number of medicines. 
Among the 20 medicines most often used by the individuals with polypharmacy, 10 (50 %) 
acted on the cardiovascular system. The second most frequent class was of medicines acting 
on the alimentary tract and metabolism. As these conditions are prevalent in the geriatric 
population, this is not a surprising finding (Carvalho et al., 2011).  
  
Geriatric individuals often have several concomitant conditions, leading to the need for 
polypharmacy. The results of the study demonstrate that polypharmacy is highly prevalent 
among geriatric patients in the city of São Paulo, which may lead to serious consequences 
for this age group (Carvalho et al., 2011).  
  
Considering the particularities of the geriatric population it is necessary to assess the 
suitability of what is being used in terms of both the choice of medicines and dosages. It 
should be stressed that individuals in the geriatric population come from very 
heterogeneous groups with regard to functional capacity, which is the result of a complex 
interaction of multiple factors, such as genetics, lifestyle, past illnesses, the quality of 
healthcare, etc. Thus, functional capacity can be very different between two individuals of 
the same age and gender. Likewise, the intensity of the pharmacokinetic and 





polypharmacy can differ considerably between individuals. Prescribers need to consider this 
variability when selecting medicines and dosages so that the functional capacity of geriatric 
patients is not compromised (Carvalho et al., 2011).  
  
Rational use of medicines in the growing geriatric population is an enormous challenge to 
public health. This complicated dilemma involves the responsibility of all links in the 
medicine chain – from the pharmaceutical industry, regulatory agencies and healthcare 
systems to health professionals and patients. Educational and administrative measures are 
needed to ensure quality medicine therapy for the geriatric population (Carvalho et al., 
2011).   
  
The study concluded that the number of medicines used per patient was large. The use of 
potentially inappropriate medicines according to the Beers Criteria was prevalent too. The 
results and conclusions of this study point out the shortcomings of the healthcare sector in 
South Africa especially with the geriatric patient population (Carvalho et al., 2011).   
  
A prospective observational study was carried out in the medicine ward during from January 
2013 to January 2014 by Maheshkumar & Dhanapal to determine the prevalence of 
polypharmacy in geriatric patients in a rural teaching hospital in India.  
  
The study included 520 hospitalized geriatric patients. Polypharmacy was observed by 
number of medicines prescribed in each geriatric patient. An average of 6 -8 medicines were 
prescribed for most patients. The prescriptions were classified according to various 
therapeutic categories based on the disease systems identified. The top three conditions 
were cardiovascular, respiratory and hepatic system. The results also showed that major 
polypharmacy was prevalent in the cardiovascular and respiratory system diseases. 
Polypharmacy was more prevalent in the males than females. The duration of hospital stay 
of geriatric patients showed an increase in major polypharmacy. (Maheshkumar & 





They concluded that polypharmacy is prevalent among geriatric patients. Interventions by 
health care professionals regarding optimal use of medicines in geriatric patients may lead 
to reduced medicine related problems that are usually associated with polypharmacy 
(Maheshkumar & Dhanapal, 2014).  
  
This study determined the prevalence of polypharmacy to various factors e.g. age, gender, 
hospital stays, therapeutic category and quantitative assessment. In assessing the results 
using these comparisons the study confirms that pharmacists can positively impact on 
polypharmacy by a number of interventions. These include: reduction in the total number of 
medicines, reduction in the number of doses, increasing patient compliance and prevention 
of adverse medicine reactions, thereby improving patients’ quality of life and decreasing 
hospital and medicine expenditure (Maheshkumar & Dhanapal, 2014).   
  
An observational study by accidental sampling to determine polypharmacy and 
inappropriate medicine use (IMU) in 100 geriatric hospitalised patients aged 65 years and 
above, in two Yogyakarta hospitals (internal medicine department), Indonesia was 
conducted by Rahmawati et al., (2007).   
  
Inappropriate medicine use was identified through a discussion forum involving the clinical 
pharmacist and senior geriatric consultant. Comparisons were made between patients 
receiving five medicines or less per day (group A) with patients receiving more than five 
medicines per day (group B) during the hospital stay. Inappropriate medicine use occurred 
in 63 events.  Total expense of inappropriate medicine use was substantial and equal to 
approximately 1.046, 11 US dollars. Of the 100 patients, 24% received more than five 
medicines per day during the duration of hospital stay (Ramhawati et al., 2007).  
  
Geriatrics are at higher risk of multiple chronic diseases. They tend to have more medicines 
prescribed than the other age groups. In addition, multiple complaints, atypical disease 





in these people, particularly in hospitals, clinics, nursing homes. The study showed a total of 
784 medicines were prescribed for geriatric patients while hospitalized, with a range of 2-20 
medicines. There were 31 patients in total who were taking 10 or more medicines.  Geriatric 
patients receive a higher number of prescriptions in hospital and in the community than do 
younger patients (Ramhawati et al., 2007).  
  
Polypharmacy was found to be the independent predictor of adverse medicine reactions.  
Earlier research, by Larson (2004) found the potential of adverse medicine reactions 
occurrence equal 6% among patient who got two kinds of medicines, 50% among the 
patient accepting five kinds of medicines and 100 % at the patient accepting eight or more 
kinds of medicines. 
 
Inappropriate medicine use in patients with five medicines or less per day was lower than 
patients with more than five medicines per day during the hospital stay. The prevention of 
inappropriate medicine use can be minimised by reducing the number of medicines used 
(stop all medicines without therapeutic benefit, goal or indication). Elimination of 
inappropriate medicine use results in decreased medicine expenditure among geriatric 
patients. The above study identified inappropriate medicine use and the cost implications 
based on this wastage. The investigation of polypharmacy was a suitable indicator for 
inappropriate medicine use in this study (Ramhawati et al., 2007).  
 
A systematic review of polypharmacy and inappropriate medicine use among geriatric 
patients was carried out by Elmstahl and Linder in Sweden (2013). The aim of the study was 
to determine the frequency of polypharmacy and inappropriate medicine use among 
subjects ≥ 65 years. Fourteen studies fulfilled the criteria for polypharmacy and ten studies 






Findings showed that five of the hospital studies reviewed had a higher polypharmacy 
prevalence (46 %-66 %) than that found in studies of the general population. This article 
shows that a significant number of geriatric patients treated with multiple medicines, and 
the prevalence of polypharmacy depended on the different care settings. The primary care 
setting had a lower prevalence of polypharmacy when compared to the hospital setting. 
They deduced that this could be due to hospital patients being frailer and having 
multimorbid conditions (Elmstahl & Linder, 2013).   
  
They concluded that polypharmacy and inappropriate medicine use were common among 
the geriatric patients. The number of medicines prescribed increased over time. They also 
confirmed a need for more prospective studies on medicine use among geriatric patients as 
polypharmacy and inappropriate medicine use are recent concepts that have emerged over 
the past two decades. There are very few published papers on these important factors in 
geriatric medicine treatment (Elmstahl & Linder, 2013).   
  
A recent single centre retrospective cohort study of 237 geriatric patients was conducted in 
a tertiary hospital in the United Arab Emirates by Al Ameri et al., (2014) to determine the 
prevalence of polypharmacy.   
  
It was found that 89 % of the included patients were taking more than five medicines and 
were exposed to at least one polypharmacy episode. They concluded that there was 
significant prevalence of polypharmacy among geriatric patients. A clear relationship 
between polypharmacy and other factors such as age, gender, level of education, number of 
medicines, medicine-medicine interactions, interventions and co-morbidities was 






A step wise approach to decrease exposure of geriatric patients to polypharmacy should be 
developed in all hospitals. This will ensure safe, effective and appropriate use of medicines 
in these specific populations (Al Ameri et al., 2014).  
  
They also concluded that strategies should be defined to closely monitor geriatric patients 
who are more likely to be exposed to polypharmacy to increase the awareness of the 
magnitude of the polypharmacy phenomenon, improve medicine therapy and minimize 
medicine intake in geriatric patients with a substantial decrease in the cost of medicines. 
This recommendation is consistent with The National Drug Policy of South Africa (Al Ameri 
et al., 2014).  
  
2.10 Conclusion  
All of the studies conducted overseas confirm that polypharmacy is prevalent in geriatric 
patients. The conclusions made by each study also emphasizes on the role of pharmacists in 
geriatric polypharmacy.   
  
Based on all the articles reviewed, there needs to be a consensus on a universal definition of 
the term polypharmacy. Many authors had differing definitions of this term. The geriatric 
population age group should also have a common definition.   
  
The use of single common definitions of these terms will assist in further research and 
studies being conducted to determine the prevalence of polypharmacy in geriatric patients. 
These can then lead to a universal standard treatment guidelines for the geriatric 
population.  
 
South African studies did not address the prevalence of polypharmacy in geriatric patients as 





conducted in South Africa to replicate international studies. Based on all of the above, the 
aim of this study is to determine the prevalence of polypharmacy in a geriatric group at a 







Chapter 3: Methodology  
  
3.1 Introduction  
In this chapter, the methodology chosen for the research is discussed. The objectives of this 
study were addressed by following an exacting and thorough research methodology. This 
section provides information on the study population, study design, and the sample that 
was selected. The statistical techniques that were used to analyse the data and interpret the 
results are also discussed in this chapter.   
  
3.2 Study Design  
A cross sectional descriptive study involving geriatric patients was utilised in order to 
address the aim and objectives of this study.   
  
Nedarc (2012) defines a descriptive cross-sectional study as a study in which the chronic 
disease or health condition and potentially related factors are measured at a specific point 
in time for a defined population. Cross-sectional studies are a "snapshot" of the frequency 
and characteristics of a health condition in a population at a particular point in time. This 
type of data can be used to assess the prevalence of certain conditions or characteristics in a 
population. In this study it was used to determine the prevalence of polypharmacy in 
geriatric patients in a private hospital.  
 
3.3 Study Area  
This was a private hospital in Pietermaritzburg in KwaZulu-Natal, South Africa. The name of 
the hospital will be kept anonymous to comply with the hospital rules and regulations 





of patients seen in outpatients is an average of 350-400 per month. The catchment areas 
include, Umgungundlovu District, Kokstad, Ixopo, Mooi River and Northern Natal1.   
  
3.4 Study Population  
These were selected from patients admitted to various wards in the hospital. From previous 
records (2013) at the hospital, an average of 180 patients from this age group is seen per 
month. The staff at casualty and admissions was informed about the data collection process 
to notify the researcher whenever a geriatric patient was admitted. 
 
3.5 Study Sample and Size  
Sample size was calculated using a sample-size calculator (see www.raosoft.com) with a 5 % 
margin of error, a 95 % confidence interval and a 50 % response distribution. A total of one 
hundred and twenty geriatric patient prescriptions were reviewed.  Each prescription was 
given a code number from one to one hundred and twenty to keep patients ‘names 
anonymous. Each photocopied prescription was reviewed. If it complied with the inclusion 
criteria, it was coded, reviewed and analysed using the data collection instrument.  
 
3.6 Inclusion/Exclusion Criteria  
3.6.1 Inclusion Criteria  
 60 years and older  
 New hospital admissions from casualty department  
 A doctor’s referral letter for hospital admission  
 First prescription only to avoid duplication  
  
                                                     





3.6.2 Exclusion Criteria  
 Patients not in this age category  
 Those that were discharged immediately after being treated in casualty   
 Patients who were admitted and had no medicine prescribed on admission   
  
3.7 Data Collection Instrument  
The prescription chart was used to extract data and a data extraction form (questionnaire) 
adapted from literature was used to extract the required variables (Annexure A).  The hyper 
pharmacotherapy assessment tool (HAT) in Figure 5 (Annexure B) adapted from Bushardt et 
al., (2008) was also used in the design of the data extraction form.  
  
3.8 Data Collection Process/Data Extraction Form  
Data collection began once permission had been obtained from the hospital and by the 
Biomedical Research Ethics Committee of the University of KwaZulu-Natal. Data was 
collected over a period of six weeks from July 2014 to August 2014. Each prescription 
meeting the study requirements was photocopied. Data collected from each chart included 
the following aspects that are outlined below. The areas that were covered in the data 
extraction form included demographic information (age, gender, and medical scheme 
membership), diagnosis, chronic diseases, allergies, and prescription medicine on admission.  
  
The conditions covered under diagnosis included: Cardiac conditions, hypertension (HPT), 
deep vein thrombosis (DVT), respiratory disorders, diabetes mellitus (DM), gastro-intestinal 
disorders (GIT), bleeding, epilepsy, psychotic disorders, orthopaedic conditions, allergies, 
groin pain, syncope, haemorrhoids, haematuria, chest pain, cholesterol, cellulitis, 
headaches, and laparoscopy. This was based on the hospital prescription chart and included 





Thirteen different chronic conditions were listed on the prescription chart as follows: cardiac 
conditions, hypertension, deep vein thrombosis, respiratory disorders, diabetes mellitus, 
hepatic disorders, thyroid, gastro-intestinal disorders, renal problems, blood disorders, 
epilepsy, psychotic and orthopaedic conditions.   
  
Questions 9a to 9g included various questions to determine inappropriate medicine use. The 
Beers’ Criteria for potentially inappropriate medicine (PIM) use in older adults was used to 
assess the medicines prescribed.   
  
The “Beers Criteria“ was first developed by Dr Mark Beers.  In 1991, 13 nationally recognized 
experts in the geriatric field developed guidelines on criteria for certain medicines that may 
lead to adverse medicine events and were considered to be inappropriate for use in geriatric 
patients in nursing homes. These criteria were most recently updated in 2012. The use of 
medicines included in the criteria is based on the risk-benefit definition of appropriateness. 
The use of a medicine is considered to be appropriate if its use has potential benefits that 
outweigh potential risks. The Beers criteria has three categories of medicine use or selection 
that are considered inappropriate for geriatric patients. These include: inappropriate 
medicine choice (medicines to be avoided in the geriatrics), excess dose (medicines at a 
dose or duration of therapy not to be exceeded), medicine-disease interaction (medicines to 
be avoided for patients with specific co-morbid conditions) (The American Geriatrics Society, 
Beers Criteria, 2012).  
  
With regards to generic or clone availability reference was made to the generics dictionary, 
the Monthly Index of Medical Specialities (MIMS), and the South African Medicines 
Formulary (SAMF). The Merck Manual and hospital formulary was also used to assess 
therapy. There were sections to determine and decrease inappropriate pharmacology. The 






Medicine review is usually carried out by each pharmacist prior to dispensing to establish 
any discrepancies and make recommendations. Side effects are common in all medicines. 
The side effect action plan on question 10 was used to determine if positive changes were 
made to the treatment plan. The final section was on optimizing dosing regimen. The lowest 
effective dose as per the manufacturers package insert was used to determine the answer 
to question 19 in the questionnaire.   
  
Bushardt & Jones (2005) further emphasize the principle of starting low and going slow. 
They encourage choice of dosages that are sensitive to a patient’s age, health condition, 
renal and hepatic function, comorbid conditions, and concurrent medicine plan. As ageing 
often alters the pharmacokinetics and pharmacodynamics of most medicines, a doctor 
should consider what effects ageing has on a medicine being used on a patient rather than 
what the medicine may do to the same geriatric patient. A dosage that is lower than normal 
can be more beneficial to the patient initially. The medicine can be titrated to suit the 
patient’s needs by regular monitoring. This is easy to do while the patient is hospitalised. 
Anticholinergic medicines, sedatives or hypnotics, hypoglycaemic medicines, and 
nonsteroidal anti-inflammatory medicines have an increased incidence of adverse effects at 
higher dosages and the above can be implemented when prescribing (Bushardt & Jones, 
2005).  
 
The percentage of encounters with an antimicrobial prescribed and the percentage of 
encounters with an injection prescribed was determined to measure the overall level of use 
of two important but commonly overused and costly forms of medicine therapy. All 
medicine prescribed was counted as a medicine. These included tablets, capsules, 
suppositories, nebulizing solutions, inhalers, ointments, creams, eye/ear/nose drops, nose 








3.9 Structure of the Data Extraction Form in Relation to Literature  
Table 1 below provides a basic structural breakdown as to how the different questions in 
the questionnaire were developed so as to address the aims and objectives of the study, in 
collaboration with the relevant literature.  
 
Table 1: Structure of Data Extraction Form in Relation to Literature  
  
Questionnaire Questions  Relevant Literature  
Questions:  
 1,2,3,4  
Al Ameri et al., (2014),  
Rozenfeld et al., (2008),  
Rahmawati et al., (2009),  
Maheshkumar  and  
Dhanapal (2014), Trumic et al., (2012)  
Questions:    
5,6,7,8  
Al Ameri et al., (2014),  
Rozenfeld et al., (2008),  
Rahmawati et al., (2009),  
Maheshkumar  and  
Dhanapal (2014), Trumic et al., (2012)  
Questions:   
9,10,11,1213,14,  
15,16,17,18,19,20  
Bushardt et al., (2008),  






3.10 Data Management  
All prescriptions were locked away. They will be destroyed once the study is completed and 
according to UKZN study data requirements.   
  
3.11 Data Analysis  
All information collected on the questionnaire was entered onto a computerized 
spreadsheet, using Microsoft Excel. Once entered into the spreadsheet, descriptive analysis 
was used to calculate mean and percentage differences. Beers Criteria was used to 
determine appropriateness of medicines prescribed.  The frequency and percentage 
differences of each component in the questionnaire were then entered into a table for 
comparison.  
 
Statistical analyses were conducted to determine if there were significant differences in 
health status, chronic conditions, gender and age. These were done by means of Chi Square 
tests. P values were also determined. The website: 
http://www.socscistatistics.com/tests/chisquare2/Default2.aspx was used to determine 
values. The South Africa Medicines Formulary and the Monthly Index of Medical Specialities 
were also used as references to answer medicine related questions.  
  
3.12 Ethical Considerations and Confidentiality  
The aim, objectives and the protocol of this study was explained and discussed with the 
pharmacy manager.  Ethics approval was obtained from the pharmacy manager of the 
private hospital in January 2014. The protocol was given full ethics approval by the 
Biomedical Research Ethics Committee, University of KwaZulu-Natal, South Africa (BREC 







3.13 Reliability and Validity 
The tool has been validated in other international studies that were discussed in the 
literature review. Some of these studies include those by Al Ameri et al., (2014), Rahmawati 
et al., (2009), Maheshkumar & Dhanapal (2014). The face validity was conducted with staff at 
the Discipline of Health Sciences at the University of KwaZulu-Natal. Data collected was also 
systematically checked before and after being captured onto the data collection instrument 
and spreadsheet. The reliability of the study was confirmed by comparisons to numerous 
international studies on the prevalence of polypharmacy in geriatric patients. The study 
however was limited to one private sector hospital and did not include data collections and 
comparisons with other private or public sector hospitals in the area. The data collection and 
subsequent results and analyses are limited to one study site and could only be compared to 
similar national and international studies only. Prescribing patterns in the public sector 
maybe different to the private sector due to the use of the Essential Drugs List and Standard 
Treatment Guidelines. The study site makes use of the hospital formulary as recommended 
by the buying group it belongs to. 
  
3.14 Conclusion  
This chapter has identified the method in which the research was conducted. The next 
chapter contains all the results of the research as well as a descriptive analysis of the results 









Chapter 4: Results  
4.1 Introduction  
This chapter presents all results on the study. It covers all the information captured from 
each prescription used and the correlating data based on the chart review questionnaire. 
Data collection spanned a period of 6 weeks between July and August 2014.    
 
4.2 Demographics of the Geriatric Patients  
In terms of demographic data (shown in Table 2), only patients aged 60 years and older 
were used in the chart review questionnaire. Patient age, gender and medical scheme 
membership were reviewed. Other demographic data regarding race, income, employment, 
education, marital and health status could not be determined as there was no direct patient 
contact and the prescription chart did not include this information.  
 Table 2 Demographic information of participants in the study (N=120)  
Variable Frequency Percentage 
Age (Years) (N=120)   
60-69   89 74.2 
70-79   24 20 
80+   7 5.8 
Gender (N=120)  
Male   53 44.2 
Female   67 55.8 
Medical Scheme Membership (N=120)  
Member   118 98.3 






4.2.1 Age of the Geriatric Patients  
The majority (74.2 %; n=89) of the study group were in the age category 60-69 years, while 
19. 2 % (n=24) were in the age category 70-79 years; and 5.8% (n=7) were in the age 
category 80 years and more. Table 2 represents the distribution of patients in the different 
age categories.   
  
4.2.2 Gender of the Geriatric Patients  
The study population consisted of 44.7 % (n=53) male and 55.8 % (n=67) female patients 
represented in Table 2. The majority of the study population were female. As can be seen 
from Figure 1, which is a comparison of the gender and age of participants in the study, all 
three age categories had more female patients. There was no significant difference (p>0.05) 
between males and females in the 60-69 years age group.  The age groups 70-79 and 80 and 
over had significant differences in gender distribution (p<0.05).   
 




























4.2.3 Medical Aid Membership of Geriatric Patients  
Table 2 indicates medical scheme membership of the patients in study. Only two of the 
patients were cash patients.   
  
Table 3 presents the descriptive results of the variables collected in this study. Each aspect 
will be described in more detail in the sections to follow.  
 
Table 3: Information on diagnoses, chronic diseases, allergies and medicine prescribed to 
participants in the study.   
 
Variable Frequency Percentage 
Diagnosis (N=120)  
Yes  117 97.5 
No 3 2.5 
Diagnosis on Admission (N=120)  
Respiratory Disorders 53 44.2 
Cardiac Problems 19 15.8 
Diabetes Mellitus 19 15.8 
Hypertension 13 10.8 
Chest Pain 8 6.7 
Other 33 27.5 
Number of Chronic Diseases (N=120)  
0  12 10 
1-2  73 60.8 
3-4  28 23.3 
5+  7 5.8 
Number of Chronic Diseases in age group 60-69 (N=120)  
0  12 10 
1-2  55 45.8 
3-4  18 15 
5+   4 3.3 
Number of Chronic Diseases in age group 70-79 (N=120)  
0  0 0 
1-2  13 10.8 
3-4  6 5 





Number of Chronic Diseases in age group 80+ (N=120)  
0  0 0 
1-2  5 4.2 
3-4  4 3.3 
5+  0 0 
Prevalence of Common Chronic Diseases  (N=120)  
Hypertension  68 56.7 
Diabetes Mellitus  40 33.3 
Respiratory Disorders  34 28.3 
Cardiac problems  32 26.7 
Orthopaedic Problems  14.2 17 
Deep Vein Thrombosis  8 6.7 
Other (Hepatic, GIT, Thyroid, Renal,  Blood, 
Epilepsy, Psychotic)    
40 33.4 
Allergies  (N=120)  
Yes  12 10 
No  108 90 
Prescription Medicine  (N=120)  
1-2  2 1.7 
3-4  28 23.3 
5+  90 75 
Average Number of Medicines Per Encounter 




Antimicrobial Usage  (N=859)  
Total number of antimicrobials prescribed  98 11.4 
Injectable Usage  (N=859)  
Total number of injections prescribed  373 43.4 
Is Medicine Appropriate?  (N=859)  
Yes  758 88.24 
Avoid  101 11.76 
No  0 0 
Availability of Generic/ Clone  (N=859)  
Yes  595 69.27 
No  264 30.73 
Is there a more effective medicine available?  (N=859)  
Yes   585 68.1 
No  274 31.9 
Is this medicine necessary?  (N=859)  
Yes  721 83.9 
No  138 16.1 





Side Effects    
Yes  859 100 
No  0 0 
Side Effect Action Plan: Stop Medicine   
Yes  95 11 
No  764 89 
Decrease Medicine Dose  (N=859)  
Yes  1 0.1 
No  858 99.9 
Change Medicine  (N=859)  
Yes  5 0.6 
No  854 99.4 
Other  158 18.3 
Inappropriate Combination Medicines  (N=859)  
Yes  0 0 
No  859 100 
Number of Prescriptions with Medicine-Medicine 
Interactions  
(N=120)  
Yes  51 42.5 
No  69 57.5 
Does diet interfere with pharmacological action?  (N=859)  
Yes  120 14 
No  739 86 
Risk of Addiction  (N=859)  
Yes  72 8.4 
No  787 91.6 
Same chemical class/pharmacological action  (N=859)  
Yes  66 7.7 
No  793 92.3 
Excessive Duration 1*  N/A  
Excessive Dosages  (N=859)  
Yes  11 1.3 
No  848 98.7 
Inappropriate Dosing Frequency  (N=859)  
Yes  5 0.6 
No  854 99.4 
Optimizing Dosing Regimen  (N=859)  
Is there lower effective dose of medicine?    
Yes  470 54.7 
No  389 45.3 
Medicine dosed more than twice daily  (N=859)  





No  486 56.6 
Notes:  
*1 Duration was not indicated on prescriptions. Prescriptions are usually reviewed at each 
dispensing to prevent excessive duration when medicine is reordered for the patient.  
 
4.3 Diagnosis in Geriatric Patients  
The chart review included presence/absence of diagnosis. A few additions were made as per 
diagnosis indicated by the admitting doctor. The diagnosis included the following: cardiac 
conditions, hypertension, deep vein thrombosis, respiratory problems, diabetes mellitus, 
thyroid condition, gastro-intestinal disorders, blood disorders, epilepsy, psychotic disorders, 
and orthopaedic conditions. A few additions were made as per diagnosis indicated by the 
admitting doctor.  The additional diagnoses were allergic reactions, groin pain, syncope, 
chest infections, cholesterol, haematuria, haemorrhoids, abdominal pain, chest pains, 
cellulitis, headaches and laparoscopy. Majority, viz. 97.5 % (n=117) patients were diagnosed 
on admission with 2.5 % (n=3) having no diagnosis.   
  
Respiratory disorders resulted in 44.2 % (n=53) admissions. This was followed by cardiac 
conditions 15.8 % (n=19), diabetes mellitus 15.8 % (n=19), hypertension 10.8 % (n=13), chest 
pain 6.7 % (n=8), and other (gastro-intestinal disorders, deep vein thrombosis, headache, 
orthopaedic problems, haematuria, haemorrhoids, allergic reactions, cellulitis, laparoscopy, 
cholesterol, groin pain, syncope, psychotic disorders, epilepsy), 27.5 % (n=33). Chest pain 
was not included under cardiac conditions. Chest pain may not always be due to a cardiac 
condition and the doctor also indicated a diagnosis of chest pain rather than cardiac 
condition. Many of the patients had more than one diagnosis on admission.  
  
4.4. Chronic Diseases in Geriatric Patients  
Patients with no chronic diseases in the total study population included 10 % (n=12). The 
majority (60.8 %; n=73) of the study population reviewed had from1-2 chronic diseases. The 
study population having 3-4 chronic diseases was 23.3 % (n=28) and five or more chronic 





The 60- 69 years age group had 12 % (n=10) with no chronic diseases listed on admission. 
This age group of 60-69 years (for 1-2 chronic diseases) also had 45.8 % (n=55), (for 3-4 
chronic diseases) 15 % (n=18) and (five or more chronic diseases) 3.3 % (n=4) out of the total 
study population respectively. The 70-79 years age group had the following: (1-2 chronic 
diseases) had zero patients, (2-3 chronic diseases) had 10.8 % (n=13) patients, (3-4 chronic 
diseases) had 15 % (n=18) and (five or more chronic diseases) had 2.5 % (n=3) patients 
respectively. The 80-89 years age group had the following: (1-2 chronic diseases) had zero 
patients, (2-3 chronic diseases) had 4.25 (n=5), (3-4 chronic diseases) had 3.3 % (n=4) and 
(five or more chronic diseases) had zero patients respectively.  
  
In each age category reviewed in the comparison, the 1-2 chronic disease category had the 
highest number of patients from the study population. The 60-69 years of age category had 
the most number of patients with 1-2 chronic diseases. Chi square testing was done and 
Table 4 resulted in the following: The chi-square statistic is 9.5744. The P-Value is 0.143758. 







Table 4: A Comparison of the number of chronic diseases in the three age groups:  
 
0 1-2 3-4 5+ Row Totals 
60-69  12  55  18  4  89  
70-79  0  13  6  3  22  
80-80+  0  5  4  0  9  
Column Totals 12 73 28 7 120  (Grand Total) 
 
The number of chronic diseases was also compared to the gender of the study population. 
The female gender with 1-2 chronic diseases had the most number of patients. This was 
followed by males with 1-2 chronic diseases. A total of 60.8 (n=73) of the study population 
had from 1-2 chronic diseases.  
 
 
Figure 2: Gender and Chronic Diseases Distribution of Geriatric Participants in the Study 
 
Chi square testing (Table 5) for the comparison of the number of chronic diseases and 
gender of the study population resulted in the following: The chi-square statistic is 1.4867. 
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Table 5: A Comparison of Gender with the Number of Chronic Diseases 
   0  1-2  3-4  5+  Row Totals  
Male  6  40  18  3  67  
Female  6  33  10  4  53  
Column Totals  12  73  28  7  120  (Grand Total)  
 
An analysis of chronic diseases was done. The most common chronic condition in the study 
population was hypertension 56.7 % (n=68), followed by diabetes with 33, 3 % (n=40), 
respiratory disorders with 28.3 % (n=34) and cardiac conditions with 26.7 % (n=32) 
respectively.  
  
4.5 Allergies in Geriatric Patients  
An important aspect of any patient history is the presence or absence of allergies prior to 
dispensing any medicine. The prescription chart includes a section where presence/absence 
of allergies has to be documented. 10 % (n=12) of the patients had allergies listed on the 
prescription chart which included penicillin, pethidine Fresenius®, Mybulen®, codeine, 
Brufen®, and Bayer Aspirin® allergies. Penicillin allergies were the highest at 5.8 % (n=7) in 
the study population that had allergies listed on their prescription charts. Two patients were 
admitted due to an allergic reaction to penicillin. The dispensing pharmacist is required to 
double checks a prescription for allergies prior to dispensing. However, these cases illustrate 
that errors might be made.  
  
4.6 Total Number of Prescription Medicines per Geriatric Patient  
The 120 patients were prescribed a total of 859 medicines. The average number of 
medicines per patient was 7.2 (range of 2-21). The average number of medicines was 
calculated by dividing the total number of medicines by the total number of patients. This 
was also used to measure the degree of polypharmacy. These include medicines prescribed 
on admission, medicines transcribed from the admitting prescription and patient’s chronic 
medicines listed on the prescription chart. Patient’s chronic medicine was not always 





be under-estimated. The majority of the study population, 75 % (n=90) received 5 and more 
medicines. Only 23.3 % (n=28) received 3-4 medicines. The lowest number of patients in the 
study population were those receiving 1-2 medicines, with a 1.7 % (n=2) record.   
  
Prescription medicine use was assessed according to gender of the study population. 
Polypharmacy was more prevalent in females when compared to the males. Females had a 
prevalence of 41.7 % (n=50) when compared to the males having a prevalence of 34.2 % 
(n=41). There was no significant difference between males and females using 1-2 medicines 
(p<0.05). There was no significant difference between males and females using 3-4 
medicines (p<0.05). There was a significant difference between males and females using five 
and more medicines (p>0.05).  
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Tables 6 and 7 which compared prescription medicine use to gender resulted in the 
following: The chi-square statistic is 1.2743. The P-Value is 0.528802. The result is not 
significant at p < 0.05. 
 
Table 6: A Comparison of Prescription Medicines per Gender 
   1-2  3-4  5+  Row Totals  
Male  1  12  41  54  
Female  0  16  50  66  
Column Totals  1  28  91  120  (Grand Total)  
 
Table 7: Chi- Square of Prescription Medicines per Gender 
   1-2  3-4  5+  Row Totals  
Male  1  (0.45)  [0.67]  12  (12.60)  [0.03]  41  (40.95)  [0.00]  54  
Female  0  (0.55)  [0.55]  16  (15.40)  [0.02]  50  (50.05)  [0.00]  66  
Column Totals  1  28  91  120  (Grand Total)  
 
Prescription medicine use was assessed for each age category. The 60-69 years age group 
had the highest prevalence of polypharmacy with 55.8 % (n=67) of the total study 
population. Polypharmacy decreased with the 70-79 years age group to 14.2 (n=17). 
Polypharmacy was lowest for the eighty and over age group with a value of 5.8 % (n=7) of 
the total study population respectively. Polypharmacy was prevalent in each age category. 
Each age category had few patients using from 1-2 and 3-4 medicines when compared to 







Figure 4 Prescription Medicines per Age Category of Geriatric Participants in the Study 
 
Tables 8 and 9 which covered a comparison of prescription medicine use with the three age 
categories resulted in the following observations: The chi-square statistic is 0.9059. The P-
Value is 0.923706. The result is not significant at p < 0.05. 
Table 8: A Comparison of Prescription Medicines per Age Category 
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60-69 70-79 80-80+ Row Totals 
1-2  2  0  0  2  
3-4  21  4  2  27  
5+  67  17  7  91  
Column Totals 90 21 9 120  (Grand Total) 
 
60-69 70-79 80-80+ Row Totals 
1-2  2  (1.50)  [0.17]  0  (0.35)  [0.35]  0  (0.15)  [0.15]  2  
3-4  21  (20.25)  [0.03]  4  (4.72)  [0.11]  2  (2.02)  [0.00]  27  
5+  67  (68.25)  [0.02]  17  (15.92)  [0.07]  7  (6.82)  [0.00]  91  





4.7 Percentage of encounters with an antimicrobial prescribed in the study population  
This was determined to measure the overall level of antimicrobials prescribed. Topical, oral 
and injectable antimicrobials were included. The hospital has an antimicrobial stewardship 
programme to minimize unintended consequences of antimicrobial use. The number of 
patient encounters during which an antimicrobial was prescribed was divided by the total 
number of medicines in the study, multiplied by 100. There were 11.4 % encounters (n=98). 
The appropriateness/inappropriateness of this fairly low value will be addressed in the 
discussion.  
  
4.8 Percentage of encounters with an injection prescribed in the study population  
This was determined to measure the overall level of use of injections which is a costly form 
of medicine therapy. The percentage use was calculated by dividing the number of patient 
encounters during which an injection was prescribed by the total number of medicines 
prescribed in the study, multiplied by 100. There were 43.4 % (n=373) encounters. This was 
close to 50 % of total medicine encounters and is considerably high. The 
appropriateness/inappropriateness of this value will be addressed in the discussion.  
  
4.9 Appropriateness of Medicine in Geriatric Patients  
All medicines were assessed using Beers Criteria. The options of a yes, no or avoid answer 
were available. Of the 859 medicines prescribed, 88. 24 % (n=758) were appropriate and 
11.76 % (n=101) should be avoided as per Beers Criteria. The medicines prescribed, that 
should be avoided included, benzodiazepines ( Ativan®, Azor®, Stilnox MR®, Dormonoct®, 
Imovane®, Ivedal®, Xanor SR®), Insulin, sliding scale (Novorapid®), Gastrointestinal 
(Maxolon®), NSAIDs (Rayzon® in cardiac patients, Toradol®), Tricyclic antidepressants 
(Trepilene®), calcium channel blockers (Amloc®, Felodipine®, Adalat XL 30mg®), diuretics 
(Spiractin®), benzothiazepine derivative ( Zildem® in cardiac patients). Each medicine was 
assessed for availability of a generic or clone. Regarding the total number of medicines 





Each medicine was also assessed for effectiveness. Regarding the total number of medicines 
prescribed 68, 1 % (n=585) medicines were found to be effective while 31, 9 % (n=274) could 
be replaced with more effective medicine. Examples of more effective medicine 
recommendations include: Proton pump inhibitors instead of sucralfate to treat gastro 
oesophageal reflux disease and ulcers. The mechanism of actions differed but proton pump 
inhibitors worked faster and needed single or twice daily frequency as compared to 
sucralfate. Montelukast was recommended instead of older asthma oral medicine. No 
dosage adjustment is needed in geriatric patients as well as those with hepatic or renal 
insufficiency and it has the added benefit or being administered once daily at night. The use 
of celecoxib was recommended instead of Mybulen®. The patient was constipated and on a 
macrogol laxative. By stopping the Mybulen® and prescribing celecoxib (also a lower dosing 
frequency) the patient would still be using a nonsteroidal anti-inflammatory without the 
adverse effect of constipation. This would also result in discontinuation of the laxative.  
 
Regarding the total number of medicines prescribed, 83, 9 % (n=721) were necessary and 
16, 1 % (n=138) were unnecessary. Examples of interventions to assess appropriateness 
include the following: Nitepax® was prescribed in a patient with asthma. A recommendation 
was made to the doctor to discontinue it as it is not recommended in asthmatic patients.  
 
Solphyllex® was prescribed for a diabetic patient, this was changed to Pholtex Forte®. One 
patient was prescribed Vimovo® and Arcoxia®, both are non- steroidal ant-inflammatory 
medicines. A recommendation was made to discontinue one agent. Ivedal® a 
benzodiazepine was often prescribed in the study population. The Beers Citeria does not 
recommend the use of this medicine in geriatric patients. The use of sliding scale insulin is 
not recommended in geriatric patients and doctors were informed of this. However this a 







All medicines have side- effects. The intervention options were to stop the medicine, 
decrease the dose or change the medicine if it would be to the patients benefit. The 
medicines reviewed for this question included antimicrobials, benzodiazepines, analgesics, 
cough mixtures, multivitamins, medicines for nausea and vomiting, constipation, 
nonsteroidal anti- inflammatory medicines, topical applications and Venofer®. Regarding the 
total number of medicines prescribed, 11 % (n=95) were stopped and 0.6 % (n=5) were 
changed to alternative treatment. Recommendations were also documented on the patient 
chart in the event that the prescriber was unavailable. An example of a recommendation 
regarding the prescribing of ketorolac which is not recommended in geriatric patients. It is 
frequently prescribed by certain doctors and at a higher than normal dose per day as well. 
Doctors are always advised about the doing frequency and duration of use but this 
recommendation is often overlooked. The duration of treatment for ketorolac is 48 hours 
only. Stringent measures are in place for paracetamol and parecoxib injections. Paracetamol 
is stopped after 24 hours and parecoxib is stopped after 96 hours. However especially in the 
elderly a shorter duration of parecoxib is recommended due to possible negative effects on 
the cardiac system.   
  
4.10 Decrease Inappropriate Pharmacology in Geriatric Patients  
The appropriateness of each medicine prescribed was assessed with different questions.  
There was no inappropriate use of combination medicines that would have a negative effect 
on the patients. Of the 120 prescriptions reviewed, 42.5 % (n=51) had medicine-medicine 
interactions. Diet, which included alcohol intake was found to affect 14 % (n=120) was 
observed. There was a risk of addiction regarding 8.4 % (n=72) medicines prescribed. There 
was a 7.7 % (n=66) observation of two or more medicines of same pharmacological class or 
pharmacological action being used. Regarding excessive duration and excessive dosages, 1.3 
% (n=11) was observed. There was a 0.6 % (n=5) observation of inappropriate dosing 
frequency. Excessive dosing frequencies were observed with nebulising solutions. It is 
commonplace to observe that they are prescribed to be used every two hours. Fluticasone 
which is recommended as a daily dose was sometimes prescribed to be used twice or three 





duration did not have a value as prescriptions did not have duration of treatment on them.  
A guide for sensible prescribing in older people has been included by Tidy (2014) (Annexure 
D).  
  
4.11 Optimize Dosing Regimen in Geriatric Patients  
Optimizing medicine therapy is an essential part of caring for a geriatric patient. The process 
of prescribing a medicine is complex. It includes: deciding that a medicine is needed 
according to the diagnosis, deciding on the most appropriate medicine, calculating a dose 
and dosing regimen suited to the patient's physiologic status, monitoring for effectiveness 
and toxicity, counselling the patient about potential side effects, and reasons for a doctor 
visit. Polypharmacy increases the frequency of non -compliance or confusion with dosing. 
Geriatric persons, especially those with low health literacy, are not able to efficiently 
consolidate prescription regimens to optimize a dosing schedule. The Institute of Medicine 
has proposed a standardized schedule for specifying medicine dosing (morning, noon, 
evening, bedtime), recognizing that 90 percent of prescriptions are taken four or fewer 
times daily (Rochon, 2014).  
  
Two factors were used to optimize dosing regimen. A 54.7% (n=486) was observed in 
determining if there was a lower effective dose of the medicine. There was a 43.4 % (n=373) 
observation of patients having medicines dosed more than two times per day. 
Recommendations were made to change certain medicines to alternatives that needed once 







Chapter 5: Discussion  
  
5.1 Introduction  
The main objective of this study was to determine the prevalence of polypharmacy in a 
geriatric population group admitted to hospital. Other objectives were to determine the 
reasons for multiple medicine prescriptions based on the health status, chronic diseases and 
number of medicines, to determine an appropriate management process and to 
recommend strategies to pharmacists to assess geriatric patients with multiple medicine 
regimens and to make suggestions when necessary. One hundred and twenty prescription 
charts were reviewed, and 75 % (n=90) of the patients received 5 and more medicines. 
Polypharmacy was evident from the results obtained.  
  
5.2 Demographics of the Geriatric Patients  
5.2.1 Age of the Geriatric Patients  
As discussed previously, age is one of the risk factors of polypharmacy.  The largest portion 
of the study group was in the youngest age category between ages 60-69 years. A clear 
relationship was found between polypharmacy and age and gender on evaluation of the 
data analysis which will be discussed below.  
 
The Al Ameri et al., study (2014) and the Maheshkumar and Dhanapal study (2014) also had 
the greatest number of participating patients in the 60-69 years age group and the lowest 
number of participating patients in the 80 and over age group which is consistent with this 
study.  
 
Hong- Ah et al., (2013) prevalence and predictors of polypharmacy among Korean geriatric 
also had the most patients in the younger age category. Among the patients, 6.7 % were 





5.2.2 Gender of the Geriatric Patients  
A gender comparison of the study population confirmed that there were more females in 
the three different age categories. An article by Kirkwood (2010), an experimental 
gerontologist points out that women are more resilient than men from birth through to 
extreme old age. He reaffirms women outlive men by about five to six years. By age 85 there 
are approximately six women to every four men, at age 100 the ratio is more than two to 
one and by age 122, the current world record for human longevity, the score stands at one-
nil in favour of women. On comparing the age category 70-79 years and 80 and over, the 
females outnumber the males by large percentage differences, which reaffirm Kirkwood’s 
statements that women outlive men as they get older (Kirkwood, 2010).  
  
Females constituted 60.0 % of the total study population in Korean geriatric patients. (Hong- 
Ah et al., 2013). This study was consistent with Hong-Ah et al., (2013) study as there were 
55.8 % (n=67) females and 44.2 % (n=53) males in the study population.  
  
5.2.3 Medical Aid Membership of Geriatric Patients  
Critical illnesses are more common in geriatric patients than in younger people. Private 
healthcare in South Africa is very expensive. To get good quality treatment without medical 
aid is beyond the reach of most individuals. Many geriatric persons on a pension cannot 
afford medical aid and are assisted by family in payment of medical aid premiums. 
Fortunately medical aid is opened to any South African, irrespective of age (Medical Aids, 
2015).  The majority of the study population had medical aid membership. Notably, medical 
aid membership was associated with polypharmacy in the Hong- Ah and colleagues study 
(2013). This study also displayed the same pattern.  
  
5.3 Diagnosis of the Geriatric Patients  
The majority of the patients had a diagnosis, with only a small percentage having no 





important so that a patient’s treatment plan will target the underlying process rather than 
an isolated symptom (Hanger, 2012).  
  
No one wants to go into a hospital for any reason. Foltz-Gray (2012) confirmed the common 
reasons that geriatric patients get admitted to the hospital. In 2009, 543 000 adults over the 
age of 65 years were hospitalized for an irregular heartbeat (cardiac arrhythmias). In 2009, 
751 000 adults over 65 years entered the hospital for congestive heart failure. More people 
are living longer and this includes people with heart disease. With the passage of time, there 
is damage/weakening of the heart muscles. This may progress to heart failure. In 2008, 822 
500 people with chronic obstructive pulmonary disease (COPD), age 40 years and over, were 
admitted to hospital. Smoking is the primary cause of COPD, which includes emphysema and 
chronic bronchitis. In 2009, 753 000 adults over 45 years were hospitalized for coronary 
atherosclerosis, or a blockage of blood flow to the heart from the build-up of fatty plaque 
(coronary atherosclerosis). In 2009, 655 000 adults were admitted to hospital because of 
diabetes. Obesity, lack of exercise and age 45 years and older are three prominent risk 
factors for type 2, or adult-onset, diabetes. Common reasons for hospitalization due to 
diabetes include strokes, heart attacks, ulcers and dehydration from increased blood sugar 
levels. Medicine problems and adverse medicine reactions resulted in 1.9 million hospital 
stays in 2008. Medicines most commonly leading to this included: corticosteroids, 
anticoagulants, sedatives and hypnotics. Pneumonia, resulted in 886 000 admissions in 
2009. The ageing process weakens the immune system. Geriatric persons are more prone to 
bacterial and viral pneumonia. Other conditions like diabetes, stroke and flu can predispose 
you to pneumonia as well. In 2008, stroke resulted in 892 300 hospitalizations (Foltz-Gray, 
2012).  
  
Data from a four-year study of 11.5 million Medicare enrolees show that even limited 
exposure to fine particle air pollution from a motor vehicle exhaust and power plant 
emissions enormously increased the risk for cardiovascular and respiratory disease among 





Ageing also affects the respiratory system. The maximum function sees a gradual decline. 
The age-related changes in the lungs include: decreased peak airflow and gas exchange, 
decreased measures of lung function such as vital capacity (the maximum amount of air 
breathed out following a maximum inhalation) and weakening of the respiratory muscles. 
(Merck Manual, 2013).  
 
Acute and chronic pulmonary problems, pose a threat to the lives of the geriatric population 
more than diseases involving any other organ system. Pneumonia is the third most common 
cause of death in the geriatric population, affecting over one million Americans each year, 
often at the end of life. Many viral infections can prove to be fatal for older people. The 
comorbidities of age exacerbate the health of geriatrics with respiratory disorders. Common 
acute and chronic pulmonary problems are often misdiagnosed or overlooked in the 
geriatric (Buckner et al., 2007).  
 
Heart disease is very common in geriatric patients and is often the leading cause of death 
(Jackson & Wenger, 2011). The increase in the number of geriatric patients has led to an 
increase of patients with heart disease and hypertension (Virdis et al., 2011). The geriatric 
population increasingly comprises a larger portion of newly diagnosed diabetic patients. In 
1993, 41 % of the 7.8 million people diagnosed with diabetes were over 65 years of age 
(Chau & Edelman, 2001).  
 
In this study, respiratory disorders were a leading cause of hospital admission. Respiratory 
disorders included asthma, bronchitis, pneumonia, tuberculosis and other lung diseases. 
This was followed by cardiac conditions (angina, congenital, rheumatic fever), diabetes 
mellitus (hyper/hypoglycaemia) and hypertension. On evaluating the top four diagnosis on 
admission it is apparent that these are in correlation with many of the articles as discussed 
above. The different diagnoses observed on admission are also an indication that patients’ 





5.4 Chronic Diseases in Geriatric Patients  
According to the American Society of Consultant Pharmacists, the most common chronic 
diseases afflicting the geriatric are: Adult onset diabetes, Arthritis, Kidney and bladder 
problems, Dementia, Parkinson’s disease, Glaucoma, Lung disease, Cataracts, Osteoporosis, 
Enlarged prostate, Alzheimer’s disease, Macular degeneration, Depression, Cardiovascular 
disease (Parentgiving, 2015).  The prevalence of chronic conditions, based on pharmacy 
claims data, in those aged ≥70 years in Ireland is high, with a significant level of co-morbidity 
(Naughton et al., 2015).  
  
Cardiovascular disease (CVD), which included hypertension, was the most common at 72 %. 
Second was central nervous system (CNS) conditions at 37 %, musculo-skeletal conditions at 
28 % was third, upper gastrointestinal (GI) at 24 % was fourth and respiratory at 14 % was 
fifth. Diabetes mellitus, thyroid disease and glaucoma occurred in 5–8 % of this population, 
and cancer therapy was received by 4 %. There was a high level of co-morbidity, with two 
chronic diseases experienced by 27 % (86,514), three conditions by 19 % (60,930) and four 
or more conditions by 14 % (44,035) of the population (Naughton et al., 2015).  
  
Research by Phaswana-Mafuya et al., (2008) to determine the prevalence of chronic 
noncommunicable diseases (NCDS) and associated factors among older adults in South 
Africa confirmed that the prevalence of chronic NCDs was 51.8 %. The prevalence of 
multimorbidity (≥2 chronic conditions) was 22.5 %. They found that the most common 
chronic NCDs reported globally included cardiovascular diseases, DM, cancer, and chronic 
respiratory diseases. This is also the case in South Africa.  The most prevalent chronic NCDs 
reported in this study were hypertension (30.3 %) and arthritis (24.7 %). The prevalence of 
hypertension was higher among women (63.8 %), African Blacks (71.8 %), wealthier 
individuals (47.1), married persons (47.7 %), and urban residents (69.7 %). The distribution 
of arthritis was similar to that of hypertension, being higher among women (66.6 %), African 
Blacks (64.1 %), wealthier individuals (47.3 %), married persons (43.6 %), and those residing 





(2.9 %) (Phaswana-Mafuya et al., 2008). Cardiovascular, respiratory and hepatic system 
conditions accounted for top three chronic diseases (Maheshkumar & Dhanapal, 2014).  
  
The Moodley (2000) study had hypertension as the most common chronic disorder in 64.8 % 
of the study population. This study also had hypertension as the leading chronic condition in 
56.7 % (n=68) patients in the study population.  The youngest age group in this study, 60-69 
years had the largest number of the study population. The results of this study are more or 
less consistent with the South African, Indian, United Arab Emirates, and Irish studies 
determining the most common chronic diseases. Hypertension, diabetes mellitus, 
respiratory disorders and cardiac problems were the top four most common chronic 
diseases observed in this study population. This study also had a prevalence of 
multimorbidity and only 10 % of the study group had no chronic conditions. The 60-79 years 
study group also had higher multimorbidity consistent with the study discussed below.  
  
Al Ameri et al., (2014) revealed in their study that multimorbidity was higher in the 60-79 
years age category, which also showed a higher exposure to polypharmacy. A total of 56 % 
of patients were involved in polypharmacy and showed multimorbidity of hypertension, 
diabetes and dyslipidemia. A clear relationship was found between polypharmacy and 








5.5 Allergies of the Geriatric Patients  
The World Allergy Organisation (WAO) describes a medicine allergy as a type of 
unpredictable reaction. The risk factors for medicine allergy include medicine factors (nature 
of medicine, degree of exposure- dose, duration, frequency, route of administration and 
cross sensitization. Host factors for medicine allergies are age, sex, genetic factors, previous 
medicine reaction, concurrent medical illness and multiple allergy syndrome. Many 
medicines are linked to the allergic reactions. Penicillins, aspirin, and sulfonamides are 
responsible for over 80 percent of allergic medicine reactions (WAO, 2014). The results of 
the study are consistent with WAO finding regarding penicillins being more frequently 
implicated in the allergy section of the questionnaire.   
  
5.6 Total Number of Prescription Medicines per Geriatric Patient  
In this study the likelihood of more than one product being used was very apparent, and the 
use of 5 and more medicines was prevalent. Each age category had a high prevalence of 5 
and more medicines prescribed. Females also overtook the males in the 5 and more 
medicines category.   
 
Al Ameri et al., (2014) revealed in their study a clear relationship between polypharmacy 
and age and the higher the number of medicines found, the greater the risk of 
polypharmacy. It was indicated that 89 % of geriatric patients, aged from 60-79 years old 
were taking more than five medicines and were exposed to at least one polypharmacy 
episode. In addition the same age group had the maximum number of incidences of 
consuming more than nine medicines (Al Ameri et al., 2014). On combining these two age 
groups, 60-69 years and 70-79 years, as a comparison to the Al Ameri et al., (2014) study, 70 
% (n=84) of the study participants were taking 5 or more medicines also confirming the 
relationship between polypharmacy and age. The lowest polypharmacy was seen in the 80 






The Maheshkumar and Dhanapal study (2014) also had the highest prevalence of 
polypharmacy in the age group 60-69 years. Their study also showed a decrease in 
polypharmacy as the patient went over the age of 70 years and the researcher found the 
same pattern in this study. Geriatric people receive a higher number of prescriptions in 
hospital and in the community than do younger patients. The sampled geriatric hospitalized 
patients had 36 patients taking more than five medicines per day (Rahmawati, et al., 2009).   
 
The Al Ameri et al. (2014) study showed that more males were exposed to polypharmacy 
than females. The Maheskumar and Dhanpal study (2014) had more females being exposed 
to polypharmacy. Granero and colleagues (2010), has shown that there is no association 
between polypharmacy and gender.    
 
The average number of medicines per encounter to measure the degree of polypharmacy in 
this study was 7.2. On referring to the definition of polypharmacy for the purposes of this 
study, it is apparent that polypharmacy is prevalent.  
  
5.7 Percentage of encounters with an antimicrobial prescribed in the study population  
To promote rational medicine use in South Africa, which is a developing country, it is 
important to assess medicine use pattern. This can be done using WHO medicine use 
indicators, which has been done for the study population (WHO 1993). The percentage of 
encounters with antimicrobials was calculated to determine the overall use of a costly form 
of medicine therapy. An antibiotic stewardship programme is being run in the intensive care 
units in this hospital which may have contributed to a lower figure. Pharmacy also reviews 
all antibiotic prescriptions. Oral antibiotics are reviewed after a five day course is dispensed 
in the event of a reorder. In the intensive care units and high care, antibiotics are reviewed 





(2013) study had 58.1 % encounters with an antimicrobial prescribed compared to 11.4 % in 
this study. The low percentage of antimicrobial encounters also highlights the importance of 
an antibiotic stewardship programme as this has resulted in a decrease in antimicrobial 
therapy. Future studies at the hospital can further assess and highlight the positive impact 
of antibiotic stewardship when comparisons are made of antimicrobial usage in wards not 
exposed to the programme.  
  
5.8 Percentage of encounters with an injection prescribed in the study population  
This percentage of encounters was calculated to determine the usage of another expensive 
form of medicine therapy (WHO 1993). The percentage of encounters was just under 50 % 
which is high and also included the use of antimicrobial injections. According to WHO 
(1993), an injection was prescribed in 37 % of all consultations. A study by Desalegn (2013) 
in Ethiopia had 38.1 % of encounters with an injection; this study however was not 
restricted to the geriatric population. Overprescribing is often caused by medicine therapy 
not being re-evaluated over time with the consequence that medicines continue to be 
prescribed even though the indication for their use is no longer present. Certain medicines 
in many hospital charts are reviewed daily to prevent excessive duration. The same was 
done on charts being reviewed for the study. E.g. Rayzon® duration is recommended for 96 
hours, paracetamol injection is dispensed for 24 hours and a further two day supply is only 
allowed in the intensive care units after it is reordered by the prescriber. The high 
percentage of encounters with an injection highlights that pharmacist interventions need to 







5.9 Appropriateness of Medicine in the Geriatric Patients  
Polypharmacy places geriatric persons at a greater risk of inappropriate prescribing. (Hajjar 
et al., 2007). Beers Criteria was used to determine if the medicines prescribed were 
appropriate. The prevalence of potentially inappropriate medicines has been evaluated in 
numerous studies since 1990. This has been seen in long- term care, outpatient, acute care 
and community settings. Even though this problem has been highlighted, the use of 
potentially inappropriate medicines is prevalent in geriatric patients (American Geriatrics 
Society, 2012). Willcox et al., (1994) concluded in their study that physicians prescribe 
potentially inappropriate medicines for a large percentage of geriatric persons living in the 
community, increasing the risk of adverse medicine reactions. In their study, 79.6 % of all 
geriatrics over age 65 received potentially inappropriate medicines. The Delphi consensus 
technique was used as an outcome measure.  
  
Aparasu and Mort (2000), reviewed literature using Beers Criteria for potentially 
inappropriate medicines (PIMs) in geriatrics. They reviewed each study regarding the 
methodology used. They also assessed the prevalence and the degree of inappropriate 
medicines prescribed. Differences in methodology were observed. However there were 
some consistent patterns in the various healthcare settings. They observed that researchers 
adjusted the Beers criteria to examine inappropriate medicine use in the geriatric in the 
various health care settings. Results showed that almost one out of four (23.5 %) and one 
out of seven (14.0 %) geriatric patients received a potentially inappropriate medicine 
according to the Beers list of 20 inappropriate medicines. Almost every patient received one 
potentially inappropriate medicine. Long-acting benzodiazepines, dipyridamole, and 
amitriptyline were the most commonly used inappropriate medicines.   
  
Inappropriate medicine use was established by review of the medical records, a comparison 
of symptoms, diagnosis, laboratory findings and prescription medicines. Inappropriate 





therapy, non-medicine treatment is more beneficial, therapeutic duplication, and treatment 
of an avoidable adverse medicine reaction. Inappropriate medicines were classified and 
encoded using the MIMS Indonesia 105th Edition. (Rahmawati et al., 2009). The evaluation 
of inappropriate medicine use in this study did not have access to laboratory findings. There 
is also no clinical pharmacist or geriatric consultant available at the study site.   
  
Inappropriate medicine use occurred in 63 cases (63 %) of the study population. 
Unnecessary medicine therapy accounted for 117 events. A 0-6 range of problems was a 
consequence of the high frequency of inappropriate medicines prescribed. Prior to 
prescribing any new medicine, the need for the medicine should be re- evaluated and a non-
pharmacologic option should be considered (Rahmawati et al., 2009).  This study had a very 
small percentage of potentially inappropriate medicines when compared to the Aparasu and 
Mort (2000) and the Rahmawati and colleagues study (2009).   
  
5.10  Decreasing Inappropriate Pharmacology in the Geriatric Patients  
The study of polypharmacy in the geriatric showed that comprehensive geriatric assessment 
(CGA) is an efficient way to decrease polypharmacy. Inappropriate medicine use is also 
curtailed. Health care personnel benefit from this assessment by being able to prioritize the 
different chronic conditions. This culminates in positive pharmacological treatment in 
geriatric patients. The patient's prognosis is also important in the treatment process. The 
most appropriate medicine treatment plan should combine evidence-based clinical practice 
guidelines with data gathered from the comprehensive geriatric assessment. Socioeconomic 
factors should also be considered. A medicine review of each geriatric patient should be 
done quarterly and the frequency should be increased as the number of chronic diseases 
increases (Sergi et al., 2011).   
  
Guidelines for a medicine review for ailing, ageing patients, the Pill Pruner, has been 





Pruner was carried out at Christchurch Hospital on two different groups of 500 hospitalised 
patients aged over 75 years. A total of 70 % of the patients experienced polypharmacy. Prior 
The Pill Pruner project led to a drop in the number of discharge medicines prescribed. The 
project resulted in discontinuation of over 1000 medicines. These included: loop diuretics, 
antiplatelet medicine, statins, ace inhibitors, beta-blockers and benzodiazepines. Patients’ 
health was not compromised by this (Hanger, 2012).  
  
A study to determine the benefits of pharmacists’ interventions was conducted by Gillespie 
et al., (2009). The very old age group of 80 years and over were the study population. For 
the intervention group, there was a 16 % reduction in hospital admissions and a 47 % 
reduction in emergency department visits. Readmissions due to adverse medicine reactions 
were greatly reduced by 80 %.  
  
Growing older changes pharmacokinetics and pharmacodynamics. This increases the risk of 
adverse medicine reactions. It is also worth remembering that patients aged >65-70 years 
are seldom enrolled in clinical trials. Evidence from research in younger patients cannot be 
applied to geriatric patients (Tidy, 2014).  
  
Side effects may present in older patients in nonspecific ways. Most medicines can lead to 
the side effect of confusion. Constipation, dizziness, dry mouth, blurred vision are very 
common side effects in the geriatric. Falls are also often associated with medicine in this age 
group. When assessing symptoms in the geriatric patient, pharmacists should always review 
their medicines. Establish whether or not this might be iatrogenic disease. A side effect of 
non-steroidal anti-inflammatory medicines is gastro-intestinal bleeding. This can have 
serious consequences for the geriatric patient. Heart failure and impaired renal function can 
be made worse. An assessment of side effects will assist in determining if a patient’s 





This study is to determine the prevalence of polypharmacy in geriatrics. The most consistent 
risk factor for adverse medicine reactions is the number of medicines being taken and the 
risk rises exponentially as the number of medicines increases (Tidy, 2014).  
  
Many studies in the literature highlight that adverse medicine effects occur with geriatrics 
because of age-specific metabolic changes, non-compliance, and adherence. Therefore a 
well-designed interprofessional supervision and close monitoring is essential, for this group 
to reduce aspects of unnecessary prescribing, medicine- medicine interactions and negative 
results on health outcomes (Al Ameri et al., 2014).  
  
5.11  Optimize Dosing Regimen in the Geriatric Patients  
Al Ameri et al., (2014) states that multiple medicines usage increase the chances of poor 
compliance or confusion with dosing. Caution must be taken in determining medicine doses 
as higher doses and decreased clearance usually prolong a medicines half-life (Al Ameri et 
al., 2014).  
 
Regarding question 20, ideally medicine should be dosed once or twice daily but this is 
almost impossible. Many medicines need to be given three times a day (Bushardt & Jones, 







Chapter 6: Conclusion  
  
6.1 Introduction  
In this chapter, the researcher attempts to interpret the findings of chapter 4. Each aspect of 
the aims and objectives of the study will be addressed based on the findings of the study. 
Recommendations are then made whereby improvements can be made to decrease the 
prevalence of polypharmacy in geriatric patients. The final and concluding remarks are made 
as well.  
  
6.2 Findings from the Study  
  
6.2.1 Findings from the Literature Review  
The results of the findings show that there is a prevalence of polypharmacy in geriatric 
patients in the private hospital setting. This is consistent with the various articles reviewed 
on studies around the world regarding the prevalence of polypharmacy in geriatrics in 
various care settings around the world. More research is needed to highlight the 
consequences associated with IMU use in geriatric patients. The results of the study 
reiterate Al Ameri et al., (2014) and Hong- Ah et al., (2013) studies confirming that the 
prevalence of polypharmacy is widespread among geriatric patients.   
  
6.2.2 Findings from the Research  
The results of the research surrounding polypharmacy in relation to age, sex, medical aid 
membership, diagnosis, chronic conditions, medicine doses, inappropriate pharmacology 
optimization of dosing regimen indicate that all are contributing factors to the prevalence of 
polypharmacy. The youngest age group in the 60-69 years age category had the most 






6.3 Study Limitations  
The study was assessed from reviewing patient prescription charts and not from 
interviewing patients or healthcare professionals. It was difficult to ascertain whether the 
study population was using any over the counter medicines, this may have resulted in an 
underestimate of the prevalence of polypharmacy.  
  
The full set of criteria was not applied (Beers Criteria) as most of the prescriptions reviewed 
did not have a duration of treatment and only the first prescription on admission was 
reviewed. Lack of clinical data which included laboratory results, blood pressure and glucose 
monitoring were also not available. This may have resulted in an under estimation of the full 
extent of the negative problems associated with polypharmacy in the geriatric patients.  
  
6.4 Recommendations  
Health care personnel can adopt an informed approach to address the needs of the geriatric 
population regarding polypharmacy. Health care professionals need to know about the risks 
associated with polypharmacy and thoroughly review all medicines at each patient 
encounter to prevent polypharmacy from occurring. Strategies for pharmacists to manage 
polypharmacy can include medicine review, communication with the prescriber and patient, 
reduction in a geriatrics regimen to the fewest possible essential medicines. Prescribers and 
dispensers can utilize the information to decide whether the medicine is essential and if the 
geriatric can tolerate possible interactions or adverse effects.   
  
Pharmacy and Medical Schools should provide ongoing education to all health professionals 
regarding rational medicine therapy in geriatric patients. Pharmaceutical companies should 
also provide training to healthcare professionals regarding the most problematic medicines 
in geriatric therapy. Geriatric patients should also be exposed to educational programmes 





 6.5 Conclusion  
This study allowed the researcher to determine that polypharmacy is prevalent in geriatric 
patients in South Africa. Clear, feasible recommendations have been made to decrease the 
prevalence of polypharmacy in geriatric patients. The results of this study can be used by 
healthcare professionals to be aware of the prevalence and scope of polypharmacy.  The 
results can be used by the pharmacy team at the study site to put systems in place for 
interventions that will impact positively on polypharmacy. More research is needed to 
address prescribing trends across the country and the impact of inappropriate medicine use 
in the geriatric population. The scope for further research following this study is significant 
as the health care industry in South Africa is currently going through a transition to a 
National Health System (NHS).   
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Annexure A: Data Extraction Form/Questionnaire  
  
Demographics:  
1. Age group  
Table: 1  
Age-group  
60-69  70-79  ≥80  
  
2. Sex  
Table:2  
Sex  
Male  Female  
  
3. Medical aid  
Table:3  
Medical Aid  
Yes  No  
  
Diagnosis on Admission Day  
4. Diagnosis  
Table:4   
Diagnosis   Yes   No   
  
Chronic Diseases  
5. Number of chronic diseases  
Table:5  





1 or 2  3 or 4  ≥5  
  
6. Names of chronic diseases  
Table: 6 
a.  e.  
b.  f.  
c.    
d.    
  
7. Allergies  
Table:7  
Yes with Description  No  
 
Monitor Number of Medicines   
8. Total Number of prescription medicines:  
Table:8   
Total Number of Prescription Medicines 
 
1 or 2  3 or 4  ≥5  
  
9. Names and Dosage of All Medicine  
   Table:9     
      *  *  *  *  







Dosage  Indication  Is Medicine  
Appropriate for use 
in geriatric  
(YES or NO)  




(YES or  
NO)  





(YES or  
NO)  
Is this  
medicine  
necessary  
(YES or  
NO)  
              
              
*- 9. d, e, f, g Indicates Inappropriate Medicine use  
  
Table:10    
Decrease Inappropriate Pharmacology  YES  NO  Name/s of Medicine  
10. a. Are there side effects to the Medicine/s?        
11. Are there combination medicines, in which 
one of the medicines is inappropriate?  
      
12. Are  there  medicine-medicine 
interactions?  
      
13. Does diet interfere with pharmacologic 
action?  
      
14. Is there risk of an addiction from medicine?        
15. Are two or more medicines of same 
chemical class or pharmacologic action 
being used?  
      
16. Excessive duration?        
17. Excessive dosages?        









10 a. Side Effect Action Plan after Discussion with Doctor  
Table:12  
Plan  Yes  No  
Stop Medicine      
Decrease 
 Medicine  
Dose  
    
Change Medicine      
Other      
  
Table:13    
Optimize Dosing Regimen  YES  NO  
19. Is there a lower effective dose of the Medicine?      
20. Does the patient have any medicines dosed more than two times per 
day?  













Figure 5: HAT above was used in the development of the Data Extraction Form for the 





Annexure C: Ethics Approval  
 






Annexure D: A Rubric for Sensible Prescribing in Older Patients  
  
Is it needed? Consider this carefully in the context of the older patient, their medical 
problems, lifestyle and resources to cope with taking a medicine.   
Limit the range of medicines you use in older patients: it's a good idea to have a small 
formulary for older patients and to be aware of the indications, contra-indications and 
potential side-effects of these medicines in this group.   
Start low, go slow: initial dosage should be carefully considered and usually about half of 
the normal adult dose. Dose titration should be cautious and carried out in small 
increments, watching out for side-effects.  
Keep it simple: use medicine treatment plans with the lowest number, with dosing intervals 
of once or twice daily. Avoid complicated or multiple dosing regimens where possible. Avoid 
polypharmacy.  
Make it clear: avoid unclear prescribing e.g. as 'as directed', providing full dose, frequency 
and route, on first and repeat prescriptions. Use pictograms or other aids to help the patient 
take the medicine correctly.   
Review regularly: review medicine after it has been started, assess whether it should be 
continued long-term. An Irish study found that the main contributors to potentially 
inappropriate prescribing were NSAIDs taken for more than three months, PPIs prescribed 
at maximum strength for more than eight weeks and long-acting benzodiazepines given for 
longer than one month. Put systems in place for the doctor to review treatment at 
appropriate intervals. Encourage patients to dispose of old, unused medicine via their GP or 
pharmacist.   
Use teams and support: interdisciplinary approaches to prescribing, dispensing and 
monitoring of medicines are particularly useful in older patients. Liaise with colleagues to 
achieve the best for every patient. There is good evidence that involvement of a clinical 
pharmacist in the review of elderly patients' medicine improves safety and decreases 
expenditure in a community setting. (Tidy, 2014)  
